The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mestinon 60 mg Tablets

Lexon Pharmaceuticals (Ireland) LimitedPPA23176/028/001

Main Information

Trade NameMestinon 60 mg Tablets
Active SubstancesPyridostigmine bromide
Dosage FormTablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/028/001

Group Information

ATC CodeN07AA Anticholinesterases
N07AA02 pyridostigmine


License statusAuthorised
Licence Issued12/06/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back